XML 68 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - CAD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities      
Income (loss) for the year $ 62,117,601 $ (7,393,384) $ (2,683,482)
Items not affecting operating activities:      
Interest income received (210,667) (254,261) (5,590)
Unrealized foreign exchange effect on cash and cash equivalents (3,696,537) (173,740) (71,562)
Items not affecting cash:      
Change in fair value of fair value throught profit or loss assets 1,831,833 (84,892) 559,873
Interest and finance charges, net of settlement gains (losses) (274,251) (286,867) (131,148)
Share - based payments 1,820,724 1,415,639 970,796
Deferred income tax recovery (3,683,267) (2,489,902) (1,439,332)
Depreciation 11,736 39,344 136,200
Depletion 1,732,270 2,282,276 2,163,221
Impairment of royalty interest 7,256,340    
Writedown of goodwill 1,879,356 2,709,239 1,518,328
Realized (gain) loss on sale of investments 217,462 (83,345) 287,204
Gain on acquisition and sale of exploration and evaluation assets, net of derecognition of equipment (397,254) (1,335,003) (6,845,722)
Gains (losses) in an associated company, net of dilution gains (losses) and loss on derecognition (80,310,549) 491,005 312,934
Shares received from operating partners included in exploration recoveries   (810,521) (134,738)
Unrealized foreign exchange (gain) loss (332,295) 597 (67,249)
Cash flows from (used in) operations before changes in working capital (12,037,498) (5,973,815) (5,430,267)
Changes in non-cash working capital items 6,081,650 2,532,391 114,724
Total cash used in operating activities (5,955,848) (3,441,424) (5,315,543)
Cash flows from investing activities      
Acquisition and sale of exploration and evaluation assets, net of option payments received 229,065 161,048 3,005,280
Distributions from investments, net 84,246,645    
Proceeds from credit facility and loan repayments received 48,809,393    
Repayment of credit facility and loan distributions (48,027,130)    
Interest received on cash and cash equivalents 210,667 86,543 5,590
Notes receivable   (1,405,277) (542,622)
Proceeds from sale of fair value through profit and loss investments, 1,084,980 139,365 130,737
Proceeds on available for sale financial instruments     17,375
Purchase of investments in associated companies (1,781,642) (2,059,631)  
Restricted cash 152,909 (412,262) (89,402)
Purchase and sale of property and equipment, net (26,997) (24,784) (16,999)
Reclamation bonds 72,149 123,679 171,307
Total cash provided by (used in) investing activities 84,970,039 (3,391,319) 2,681,266
Cash flows from financing activities      
Proceeds from Sprott facility 6,298,166    
Repayment of Sprott credit facility (6,553,274)    
Proceeds received from private placement, net of share issue costs   6,907,228  
Proceeds from exercise of options 186,100 85,700 127,800
Total cash provided by (used in) financing activities (69,008) 6,992,928 127,800
Effect of exchange rate changes on cash and cash equivalents 3,696,537 173,740 71,562
Change in cash and cash equivalents 82,641,720 333,925 (2,434,915)
Cash and cash equivalents, beginning 3,533,611 3,199,686 5,634,601
Cash and cash equivalents, ending $ 86,175,331 $ 3,533,611 $ 3,199,686